相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
Stefanie Goellner et al.
NATURE MEDICINE (2017)
Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells
Huang-Hui Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy
Rogerio M. Castilho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Histone Acetyltransferase 1 Promotes Cell Proliferation and Induces Cisplatin Resistance in Hepatocellular Carcinoma
Xin Jin et al.
ONCOLOGY RESEARCH (2017)
MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes
Masoumeh Azizi et al.
EPIGENOMICS (2017)
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
Maithili P. Dalvi et al.
CELL REPORTS (2017)
ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC
Darina Lazarova et al.
JOURNAL OF CANCER (2017)
Identification of Predictive DNA Methylation Biomarkers for Chemotherapy Response in Colorectal Cancer
Rashidah Baharudin et al.
FRONTIERS IN PHARMACOLOGY (2017)
MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10
Ye Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients
Wang Xin Yuan et al.
ONCOLOGY LETTERS (2016)
MDR1 mediated chemoresistance: BMI1 and TIP60 in action
Soumyajit Banerjee Mustafi et al.
Biochimica et Biophysica Acta-Gene Regulatory Mechanisms (2016)
Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes
Junjian Wang et al.
CANCER LETTERS (2016)
Sensitization of androgen refractory prostate cancer cells to anti androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin
Vikas Sharma et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer
Mei-Ren Pan et al.
ONCOTARGET (2016)
Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients
Melanie Spitzwieser et al.
ONCOTARGET (2016)
Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer
Samer Alzoubi et al.
ONCOTARGET (2016)
Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells
Chih-Cheng Chen et al.
CANCER CELL INTERNATIONAL (2015)
Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer
Fu-Gui Ye et al.
CANCER RESEARCH (2015)
DNA Methyltransferase 1 Drives Transcriptional Down-Modulation of β Catenin Antagonist Chibby1 Associated With the BCR-ABL1 Gene of Chronic Myeloid Leukemia
Elisa Leo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer
Yang Li et al.
ONCOTARGET (2015)
Histone deacetylase 3 promotes pancreatic cancer cell proliferation, invasion and increases drug-resistance through histone modification of P27, P53 and Bax
Feng Jiao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the Oxidative Stress pathway
Hui Deng et al.
MOLECULAR CANCER (2014)
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Hariharan Easwaran et al.
MOLECULAR CELL (2014)
Inhibition of Euchromatic Histone Methyltransferase 1 and 2 Sensitizes Chronic Myeloid Leukemia Cells to Interferon Treatment
Sheng Wei Loh et al.
PLOS ONE (2014)
Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters
Qiong Wu et al.
ONCOTARGET (2014)
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
Alexander Roesch et al.
CANCER CELL (2013)
DNA Methylation Pyrosequencing Assay Is Applicable for the Assessment of Epigenetic Active Environmental or Clinical Relevant Chemicals
Ana-Maria Florea
BIOMED RESEARCH INTERNATIONAL (2013)
Epigenetic Resensitization to Platinum in Ovarian Cancer
Daniela Matei et al.
CANCER RESEARCH (2012)
Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Roel H. Wilting et al.
DRUG RESISTANCE UPDATES (2012)
HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins
Kwang Hwa Jung et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Activating Transcription Factor 4 Confers a Multidrug Resistance Phenotype to Gastric Cancer Cells through Transactivation of SIRT1 Expression
Hongwu Zhu et al.
PLOS ONE (2012)
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
Valerie Cortez et al.
BREAST CANCER RESEARCH (2012)
Epigenetic aberrations during oncogenesis
Maria Hatziapostolou et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1
S. Sengupta et al.
ONCOGENE (2011)
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
Praveen Rajendran et al.
CLINICAL EPIGENETICS (2011)
Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma
Jiro Kikuchi et al.
BLOOD (2010)
Histone Methyltransferase MLL1 Regulates MDR1 Transcription and Chemoresistance
Hairong Huo et al.
CANCER RESEARCH (2010)
Epigenetic regulation of cell life and death decisions and deregulation in cancer
Nabil Hajji et al.
ESSAYS IN BIOCHEMISTRY: EPIGENETICS, DISEASE AND BEHAVIOUR (2010)
Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide
N. Hajji et al.
ONCOGENE (2010)
The Critical Role of the Class III Histone Deacetylase SIRT1 in Cancer
Tao Liu et al.
CANCER RESEARCH (2009)
Global Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and Carcinoma
Hassan Ashktorab et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
miR2Disease: a manually curated database for microRNA deregulation in human disease
Qinghua Jiang et al.
NUCLEIC ACIDS RESEARCH (2009)
Selective repression of YKL-40 by NF-κB in glioma cell lines involves recruitment of histone deacetylase-1 and-2
Krishna P. Bhat et al.
FEBS LETTERS (2008)
Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells
Kenneth K. W. To et al.
MOLECULAR CANCER RESEARCH (2008)
Histone deacetylases and cancer
M. A. Glozak et al.
ONCOGENE (2007)
Histone deacetylase inhibitors: molecular mechanisms of action
W. S. Xu et al.
ONCOGENE (2007)
SIRT1 regulates the function of the nijmegen breakage syndrome protein
Zhigang Yuan et al.
MOLECULAR CELL (2007)
Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinorna cells reveals novel hyper- and hypomethylated targets
Vasyl' F. Chekhun et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers
Jairo Rodriguez et al.
CANCER RESEARCH (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Genomic DNA methylation: the mark and its mediators
RJ Klose et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
A microRNA polycistron as a potential human oncogene
L He et al.
NATURE (2005)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
The nucleosome: From genomic organization to genomic regulation
S Khorasanizadeh
CELL (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Loss of IGF2 imprinting:: A potential marker of colorectal cancer risk
HM Cui et al.
SCIENCE (2003)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
